A novel ultra-rare nonsense variant linked to PCDHGC4-related neurodevelopmental disorder in an Iranian patient

Biallelic loss-of-function variants in PCDHGC4 cause a rare autosomal recessive neurodevelopmental disorder characterized by developmental delay or intellectual disability, severe speech impairment, gait abnormalities, and variably microcephaly, seizures, and joint anomalies. The transcript-level consequence of premature termination variants is important because nonsense-mediated mRNA decay (NMD) may preclude production of a stable truncated protein. We clinically evaluated a 9-year-old Iranian Sistani boy and performed whole-exome sequencing followed by Sanger validation and segregation analysis. Variant nomenclature and exon architecture were verified against the MANE Select transcript NM_018928.3. NMD was assessed using canonical exon-junction-complex rules and the UCSC NMDetective-AI track. The patient had moderate intellectual disability, absent speech, esotropic strabismus, delayed walking, and a persistent wide-based unsteady gait, without seizures, microcephaly, or joint hypermobility at the most recent assessment. Brain MRI showed symmetric peritrigonal white-matter hyperintensities without a major structural anomaly. A novel homozygous NM_018928.3:c.1369 C > T variant was identified in PCDHGC4 ; codon-level validation corrected the protein consequence to NP_061751.1:p.(Gln457Ter). The premature termination codon lies in exon 1 of 4, 1071 nucleotides upstream of the first downstream exon-exon junction and 1219 nucleotides upstream of the final junction. Canonical rules therefore predict NMD sensitivity, whereas NMDetective-AI yielded an intermediate/uncertain score (-0.1644), close to its NMD-evading threshold. This additional family expands the phenotypic and allelic spectrum of PCDHGC4 -related neurodevelopmental disorder. The most defensible current mechanism is loss of function, with NMD predicted by the canonical positional rule but not experimentally confirmed. Patient-derived RNA studies are required to determine NMD efficiency and whether any truncated protein is produced.

Authors

Institutions

Publication Details

Journal
BMC Medical Genomics
Published
2026-11-13
DOI
https://doi.org/10.1186/s12920-026-02511-6
Primary Topic
Genetics and Neurodevelopmental Disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A novel ultra-rare nonsense variant linked to PCDHGC4-related neurodevelopmental disorder in an Iranian patient

Morteza Oladnabi, Ali Kowsari, Teymoor Khosravi
7 links
BMC Medical Genomics
Genetics and Neurodevelopmental Disorders
article

A novel ultra-rare nonsense variant linked to PCDHGC4-related neurodevelopmental disorder in an Iranian patient

Morteza Oladnabi, Ali Kowsari, Teymoor Khosravi
article en

Abstract

Biallelic loss-of-function variants in PCDHGC4 cause a rare autosomal recessive neurodevelopmental disorder characterized by developmental delay or intellectual disability, severe speech impairment, gait abnormalities, and variably microcephaly, seizures, and joint anomalies. The transcript-level consequence of premature termination variants is important because nonsense-mediated mRNA decay (NMD) may preclude production of a stable truncated protein. We clinically evaluated a 9-year-old Iranian Sistani boy and performed whole-exome sequencing followed by Sanger validation and segregation analysis. Variant nomenclature and exon architecture were verified against the MANE Select transcript NM_018928.3. NMD was assessed using canonical exon-junction-complex rules and the UCSC NMDetective-AI track. The patient had moderate intellectual disability, absent speech, esotropic strabismus, delayed walking, and a persistent wide-based unsteady gait, without seizures, microcephaly, or joint hypermobility at the most recent assessment. Brain MRI showed symmetric peritrigonal white-matter hyperintensities without a major structural anomaly. A novel homozygous NM_018928.3:c.1369 C > T variant was identified in PCDHGC4 ; codon-level validation corrected the protein consequence to NP_061751.1:p.(Gln457Ter). The premature termination codon lies in exon 1 of 4, 1071 nucleotides upstream of the first downstream exon-exon junction and 1219 nucleotides upstream of the final junction. Canonical rules therefore predict NMD sensitivity, whereas NMDetective-AI yielded an intermediate/uncertain score (-0.1644), close to its NMD-evading threshold. This additional family expands the phenotypic and allelic spectrum of PCDHGC4 -related neurodevelopmental disorder. The most defensible current mechanism is loss of function, with NMD predicted by the canonical positional rule but not experimentally confirmed. Patient-derived RNA studies are required to determine NMD efficiency and whether any truncated protein is produced.

BMC Medical Genomics
Golestan University of Medical Sciences (IR)
Golestan University of Medical Sciences
Good health and well-being
Genetics and Neurodevelopmental Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon